Furthermore, neutralization of SCF’s effects by anti-c-Kit or through pharmacologic inhibitors, reduced proliferation and migration of lung fibroblasts both from healthy donors and from SSc patients. The gene discussed is KIT; the disease is systemic sclerosis.